Merck sold $3.2 billion of its Covid oral antiviral treatment, driving first-quarter revenue growth
Merck soundly beat Wall Street estimates for its top and bottom lines, reporting earnings of $2.14 per share on $15.9 billion in revenue.
Robinhood shares fall as retail brokerage reports shrinking revenue, fewer active users
Robinhood was up against some tough comparisons in the first quarter, when interest in so-called meme stocks in 2021 fueled its rapid growth.
Intel beats but offers disappointing guidance
Intel called for weaker-than-expected second-quarter earnings and revenue as it plans exapansion through factories in the U.S. and Germany.
Amazon shares fall on bleak forecast and slowest growth since dot-com bust
Amazon gave a revenue forecast that trailed analysts' estimates and recorded a big loss on its Rivian investment.
Apple shares dip after company warns of a possible $8 billion hit from supply constraints
Apple reported earnings after the bell. Here are the results.
UBS beats expectations for the first quarter; continues to reduce Russia exposure
The bank said macroeconomic, geopolitical and market factors created a high level of uncertainty in the first three months of the year.
PepsiCo raises revenue outlook as earnings beat estimates despite higher costs
Pepsi reported a $193 million impairment charge, after taxes, as it tries to discontinue or reposition some of its juice and dairy brands in Russia.
Alphabet reports weak earnings and revenue on big YouTube miss
Alphabet reported earnings after the bell. Here are the results.
Warner Bros. Discovery shares fall as company warns on 2022 profit, messy combination of assets
Warner Bros. Discovery says 2022 will be 'a messy year,' citing 'less favorable starting position' than expected.